- Home
- ENIC vs APLS Comparison
ENIC vs APLS Comparison
Compare ENIC & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENIC
- APLS
- Stock Information
- Founded
- ENIC 2016
- APLS 2009
- Country
- ENIC Chile
- APLS United States
- Employees
- ENIC N/A
- APLS N/A
- Industry
- ENIC Electric Utilities: Central
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- ENIC Utilities
- APLS Health Care
- Exchange
- ENIC Nasdaq
- APLS Nasdaq
- Market Cap
- ENIC 3.7B
- APLS 4.4B
- IPO Year
- ENIC N/A
- APLS 2017
- Fundamental
- Price
- ENIC $2.80
- APLS $27.75
- Analyst Decision
- ENIC Buy
- APLS Buy
- Analyst Count
- ENIC 1
- APLS 19
- Target Price
- ENIC $3.90
- APLS $49.89
- AVG Volume (30 Days)
- ENIC 266.0K
- APLS 4.0M
- Earning Date
- ENIC 10-29-2024
- APLS 11-05-2024
- Dividend Yield
- ENIC 8.84%
- APLS N/A
- EPS Growth
- ENIC N/A
- APLS N/A
- EPS
- ENIC 0.01
- APLS N/A
- Revenue
- ENIC $5,287,759,941.00
- APLS $715,216,000.00
- Revenue This Year
- ENIC $16.86
- APLS $95.59
- Revenue Next Year
- ENIC N/A
- APLS $13.77
- P/E Ratio
- ENIC $4.48
- APLS N/A
- Revenue Growth
- ENIC 8.81
- APLS 162.10
- 52 Week Low
- ENIC $2.51
- APLS $24.34
- 52 Week High
- ENIC $3.53
- APLS $73.80
- Technical
- Relative Strength Index (RSI)
- ENIC 54.08
- APLS 47.09
- Support Level
- ENIC $2.64
- APLS $25.76
- Resistance Level
- ENIC $2.86
- APLS $30.80
- Average True Range (ATR)
- ENIC 0.07
- APLS 1.84
- MACD
- ENIC 0.00
- APLS 0.04
- Stochastic Oscillator
- ENIC 72.09
- APLS 52.79
About ENIC Enel Chile S.A. (Each representing 50 shares of)
Enel Chile SA is an electricity utility company, which through its subsidiaries and affiliates is engaged in the generation, transmission and distribution of electricity businesses in Chile. It operates through two segments including Generation Business and Distribution and Network Business. The Generation Business Segment is comprised of a group of electricity companies that own electricity generating plants, whose energy is transmitted and distributed to end customers. The Distribution and Network Reportable Segment is comprised of a group of electricity companies operating under a public utility concession.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.